# Executive Director, Oncology Head, Translational Development — Bristol Myers Squibb

- Location: United States
- Posted pay: $285k–$345k/yr
- Posted: Nov 18, 2026
- Status: open (checked Nov 21, 2026)
- Apply (employer's site): https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Madison---Giralda---NJ---US/Executive-Director--Oncology-Head--Translational-Development_R1608621
- Employer record: https://visajobs.io/company/bristol-myers-squibb.md

## Sponsorship history
- Tier: Employer history only
- With this exact title: 0

## Description
At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it.
Bristol Myers Squibb is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer, cardiovascular and inflammatory diseases. BMS R&D is at a critical and exciting phase of development. As it expands and integrates its portfolio, there is an opportunity for a dynamic and resourceful individual to lead our oncology efforts in Translational Development at our sites in New Jersey or Cambridge, MA.
Translational Development at BMS
Translational Development is part of the Global Research organization in BMS and leads early and late stage translational research and development activities for the early and late-stage portfolio. Translational Development supports all therapeutic areas (heme/onc, immunology, cardiovascular, and neuroscience). This group integrates scientific, strategic and business insights to lead the development of translational strategies at the franchise level and implements them in project teams to maximize the potential of BMS drugs for patients.
Summary:
Reporting to the VP, Translational Development, the incumbent will be part of the translational team based in either Cambridge, MA or NJ and will help develop translational disease and asset strategies in solid tumor disease areas for assigned programs for FIH to approval or life-cycle management of the BMS pipeline (excluding CART). Modalities include protein degraders, ADCs, TCEs and small molecules. Key responsibility of this role is to lead the breast and prostate disease area strategy and a cross functional team of asset and disease scientists with deep disease, drug development and business knowledge working closely with discovery and early development teams, late clinical development as well as the broader oncology TD team.
Responsibilities:
Leads the development of disease and asset specific translational annual goals and objectives for Translational Development (for internal /external, translational collaboration, compound specific plans, open research questions etc)
Builds disease area specific long term translational strategy and implementation across portfolio
Assists in developing and maintaining group budget and workforce plan
Represents Translational Development in cross-functional Strategy Teams and business development teams
Interfaces with commercial including early commercialization group and Medical Affairs to provide scientific support for cross-functional TD goals
Accountable for regulatory submissions, regulatory interactions, health authority interactions for the team
Communicates regularly and prepares and makes presentations for leadership and externally as required
Collaborates with TD Lab Head in setting translational lab research objectives
Collaborates with informatics, data science and biostats heads in setting translational research objectives
Collaborates with Diagnostic Head to coordinate diagnostic needs and patient selection hypotheses
Collaborates with early clinical development and discovery teams to leverage TD data and insights for early programs
Evaluating, in conjunction with BD and established teams, the potential for in-licensing opportunities that may include potential therapeutics, emerging technologies, processes or capabilities that will enhance our Drug Discovery and Early Development efforts
Liaises with key BMS research discovery and early translational groups to help formulate and execute on new hypotheses driving new clinical biomarker assays for unmet need segments, disease strategy for new targets and development candidates and ensure seamless transition of programs after proof-of-concept
Serves as translational representative on BMS cross functional Disease Strategy Team and interfaces with commercial, clinical, Project leadership and regulatory teams to define patient segments of unmet need based on rapidly evolving clinical programs and commercial landscape
Leads small and large strategic collaborations with academia and industry partners to identify biobanks, clinical trials and existing databases to collate multi-parameter genomic and clinical datasets to mine for novel biomarkers of unmet need patients in conjunction with computational biologists, data scientists and statisticians
Serves as a conduit to external thought leaders and scientific consultants
Qualifications:
MD/PhD in Oncology or related field with minimum 15 years industry setting
Track record in large and/or small companies, leading innovative efforts to deploy translational strategies
Excellent communication, managerial and scientific qualities
Ability to interact effectively across boundaries using influencing and relationship building skills.
Competence in analysis and solving of problems, and the ability to prioritize and make tradeoffs to achieve goals.
Technical Skills:
In-depth understanding of Oncology specifically Breast Cancer and/or prostate, clinical landscape, evolving therapy, competitive landscape
Strong understanding of clinical, translational and mechanistic data with therapeutics development
Strong background in genetics, cancer biology and/or immunology
Experience in deploying biomarkers for trial design including MRD guided designs, endpoints
Experience in reverse translation with discovery experience a plus
Experience in disease strategy development working cross-functionally
Understanding of late-stage drug and translational developm

> History, not a promise: past H-1B filings do not mean an employer will sponsor you or a given role. Data: U.S. DOL OFLC LCA disclosure (FY2024–FY2026 for role counts, certified LCAs) and the USCIS H-1B Employer Data Hub. Not legal advice. Methodology: https://visajobs.io/methodology
